Visualitza per autor "Kristeleit, Rebecca S"
Ara mostrant els elements 1-2 d 2
-
First-in-human phase I/II, open-label study of the anti-OX40 agonist INCAGN01949 in patients with advanced solid tumors
Davis, Elizabeth J; Martín Liberal, Juan Jesús; Kristeleit, Rebecca S; Cho, Daniel; Blagden, Sarah P; Berthold, Dominik; Vieito Villar, Maria (BMJ, 2022-10) -
Phase I/IIa, open-label, multicentre study to evaluate the optimal dosing and safety of ODM-203 in patients with advanced or metastatic solid tumours
Bono, Petri; Massard, Christophe; Peltola, Katriina J; Azaro Pedrazzoli, Analía Beatriz; Italiano, Antoine; Kristeleit, Rebecca S; Rodon Ahnert, Jordi (BMJ, 2020-12)